Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Carbidopa / Levodopa

Known as: Carbidopa and Levodopa, co careldopa, carbidopa-levodopa 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND IPX066 is an oral, extended-release, capsule formulation of carbidopa-levodopa. We aimed to assess this extended… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Background: Fatigue is a common complaint in Parkinson disease (PD). We investigated fatigue in a cohort of previously untreated… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Despite the known benefit of levodopa in reducing the symptoms of Parkinson's disease, concern has been expressed that… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Objective: To characterize the relationships between symptoms of fatigue, physical activity, physical function, and functional… Expand
  • table 1
  • table 2
Is this relevant?
Review
2002
Review
2002
Drs. David S. Goldstein and Graeme Eisenhofer (Clinical Neurocardiology Section, National Institute of Neurological Disorders and… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
1. Several studies have demonstrated a deficiency in reduced glutathione (GSH) in the nigra of patients with Parkinson's Disease… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Carbidopa/levodopa has become accepted as a primary treatment for both the restless legs (RL) syndrome and periodic leg movements… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
We studied the relative benefits of carbidopa/levodopa (25/100 mg and 50/200 mg) and propoxyphene (100 mg and 200 mg) in six… Expand
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Three cases of a syndrome resembling neuroleptic malignant syndrome are described in patients never exposed to neuroleptics. Each… Expand
Is this relevant?
Highly Cited
1974
Highly Cited
1974
Five parkinsonian patients with severe “on-off” effects from levodopa therapy also were given combination carbidopa/levodopa… Expand
  • figure 1
  • figure 2
  • figure 7
  • figure 6
  • figure 8
Is this relevant?